Prometheus Laboratories Inc., a San Diego specialty pharmaceutical and diagnostic company, has launched MyCeliacID, a do-it-yourself, saliva-based genetic test dedicated to celiac disease.
MyCeliacID identifies distinct genetic sequences associated with celiac disease, a largely undiagnosed genetic disorder that affects approximately 3 million people in the United States.
MyCeliacID is the saliva-based version of a blood test used by doctors. The test can be ordered online at MyCeliacID.com.
Celiac disease appears in individuals genetically predisposed to the disease and who consume gluten, a protein found in grains such as wheat, barley and rye.
Celiac disease damages the small intestine, interfering with the absorption of nutrients from food.
Symptoms may vary significantly from person to person and include, but are not limited to, diarrhea, anemia, abdominal pain, skin rash and weight loss.
MyCeliacID is the only test that provides individuals with their risk of developing the disease relative to the general population, Promethus said in a release, adding that MyCeliacID can virtually rule out celiac disease in a person's lifetime.
A negative test result indicates that the individual does not have the genes associated with celiac disease and is highly unlikely to develop the disease. A positive result indicates that the individual has one or more genes that predispose to celiac disease, however it is not an indication of the disease itself.
Prometheus noted that only a doctor can diagnose celiac disease.
A licensed physician will review and place the order in accordance with state and federal law after a test request is made online.
After the testing is performed, the physician will review and release the result. Test results can be accessed online via a secure link, usually within seven days from receipt of the saliva sample.
Nov. 20, 2009, 5 p.m. -- San Diego's web video news: Today's breaking major business events, economic, and financial announcements from the Daily Transcript/San Diego Source newsroom.